Hosted: Thursday, May 31, 2018
Duration: 60 Minutes
Cryoport’s Mark Sawicki, Ph.D., chief commercial officer, hosts an informational webinar where you’ll learn about legislation regarding precision medicine and its implications for supply chain requirements.
In December 2016, the U.S. Congress enacted the 21st Century Cures Act. Cryoport believes that enhanced traceability within the logistics distribution will be subjected to additional regulatory requirements due to the fragile aspect of the drug product and the disproportionate risk of improper cold chain management on the viability of the therapies.
This webinar covers traceability within cold chain logistics for precision medicine, including four key areas:
- Traceability of the identity of the therapy
- Traceability of the distribution of the therapy
- Traceability of the environmental control of the therapy
- Traceability of the equipment used in managing the environmental control of the therapy